Literature DB >> 30799622

Identification of C-6 as a New Site for Linker Conjugation to the Taccalonolide Microtubule Stabilizers.

Lin Du, April L Risinger, Samantha S Yee, Antonius R B Ola, Cynthia L Zammiello, Robert H Cichewicz, Susan L Mooberry.   

Abstract

The taccalonolides are a class of microtubule stabilizers that circumvent clinically relevant forms of drug resistance due to their unique mechanism of microtubule stabilization imparted by the covalent binding of the C-22-C-23 epoxide moiety to tubulin. A taccalonolide (8) with a fluorescein group attached with a linker at C-6 was generated, and biochemical and cell-based assays showed that it bound directly to tubulin and stabilized microtubules. This pharmacological probe has allowed, for the first time, a direct visualization of a taccalonolide binding to microtubules, verifying their cellular binding site. This C-6-modified taccalonolide showed potency comparable to the untagged compound in biochemical experiments; however, its potency was lower in cellular assays, presumably due to decreased cellular permeability. These studies provide a valuable tool to facilitate the further understanding of taccalonolide pharmacology and demonstrate that C-6 is a promising site for a linker to be added to this novel class of microtubule stabilizers for targeted drug delivery.

Entities:  

Year:  2019        PMID: 30799622      PMCID: PMC6952213          DOI: 10.1021/acs.jnatprod.8b01036

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  18 in total

1.  Novel 2-methoxyestradiol analogues with antitumor activity.

Authors:  Tina L Tinley; Rachel M Leal; Deborah A Randall-Hlubek; James W Cessac; Lynne R Wilkens; Pemmaraju N Rao; Susan L Mooberry
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

2.  Potent taccalonolides, AF and AJ, inform significant structure-activity relationships and tubulin as the binding site of these microtubule stabilizers.

Authors:  Jing Li; April L Risinger; Jiangnan Peng; Zhongliang Chen; Lihong Hu; Susan L Mooberry
Journal:  J Am Chem Soc       Date:  2011-11-08       Impact factor: 15.419

3.  Pharmacokinetic Analysis and in Vivo Antitumor Efficacy of Taccalonolides AF and AJ.

Authors:  April L Risinger; Jing Li; Lin Du; Raymond Benavides; Andrew J Robles; Robert H Cichewicz; John G Kuhn; Susan L Mooberry
Journal:  J Nat Prod       Date:  2017-01-23       Impact factor: 4.050

4.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

5.  Chemically diverse microtubule stabilizing agents initiate distinct mitotic defects and dysregulated expression of key mitotic kinases.

Authors:  Cristina C Rohena; Jiangnan Peng; Tyler A Johnson; Phillip Crews; Susan L Mooberry
Journal:  Biochem Pharmacol       Date:  2013-02-08       Impact factor: 5.858

6.  Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity.

Authors:  Tina L Tinley; Deborah A Randall-Hlubek; Rachel M Leal; Evelyn M Jackson; James W Cessac; James C Quada; Thomas K Hemscheidt; Susan L Mooberry
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

Review 7.  Microtubule inhibitor-based antibody-drug conjugates for cancer therapy.

Authors:  Kelsey Klute; Eleni Nackos; Shinsuke Tasaki; Daniel P Nguyen; Neil H Bander; Scott T Tagawa
Journal:  Onco Targets Ther       Date:  2014-12-03       Impact factor: 4.147

8.  Mechanism of microtubule stabilization by taccalonolide AJ.

Authors:  Yuxi Wang; Yamei Yu; Guo-Bo Li; Shu-Ang Li; Chengyong Wu; Benoît Gigant; Wenming Qin; Hao Chen; Yangping Wu; Qiang Chen; Jinliang Yang
Journal:  Nat Commun       Date:  2017-06-06       Impact factor: 14.919

9.  The taccalonolides and paclitaxel cause distinct effects on microtubule dynamics and aster formation.

Authors:  April L Risinger; Stephen M Riffle; Manu Lopus; Mary A Jordan; Leslie Wilson; Susan L Mooberry
Journal:  Mol Cancer       Date:  2014-02-28       Impact factor: 27.401

Review 10.  Antibody-drug conjugates--an emerging class of cancer treatment.

Authors:  Nikolaos Diamantis; Udai Banerji
Journal:  Br J Cancer       Date:  2016-01-07       Impact factor: 7.640

View more
  5 in total

1.  Unravelling the covalent binding of zampanolide and taccalonolide AJ to a minimalist representation of a human microtubule.

Authors:  Pedro A Sánchez-Murcia; Alberto Mills; Álvaro Cortés-Cabrera; Federico Gago
Journal:  J Comput Aided Mol Des       Date:  2019-05-31       Impact factor: 3.686

2.  Taccalonolide Microtubule Stabilizers.

Authors:  Samantha S Yee; Lin Du; April L Risinger
Journal:  Prog Chem Org Nat Prod       Date:  2020

3.  Elucidating target specificity of the taccalonolide covalent microtubule stabilizers employing a combinatorial chemical approach.

Authors:  Lin Du; Samantha S Yee; Karthik Ramachandran; April L Risinger
Journal:  Nat Commun       Date:  2020-01-31       Impact factor: 14.919

Review 4.  Taccalonolides: Structure, semi-synthesis, and biological activity.

Authors:  Yan Li; Yu-Feng Du; Feng Gao; Jin-Bu Xu; Ling-Li Zheng; Gang Liu; Yu Lei
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

5.  MAP7 promotes migration and invasion and progression of human cervical cancer through modulating the autophagy.

Authors:  Li Zhang; Xudong Liu; Lina Song; Hui Zhai; Chaohua Chang
Journal:  Cancer Cell Int       Date:  2020-01-13       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.